1. Concomitant monitoring of WT1 and FLT3‐ITD expression in FLT3‐ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?. Issue 5 (22nd March 2017) Authors: De Marchi, Federico; Candoni, Anna; Zannier, Maria Elena; Haley, Lisa; Lau, Bonnie Wing Yin; Fanin, Renato Journal: American journal of hematology Issue: Volume 92:Issue 5(2017:May) Page Start: E72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗